Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    This updates the page’s software/UI revision marker from **v3.5.0** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-26T15:32:25.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    UI refresh of the study details page with updated layout and navigation; core study information such as eligibility criteria and outcomes remains unchanged.
    Difference
    0.0%
    Check dated 2026-04-12T11:17:24.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; previous revision v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T20:23:05.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Footer text updated from Revision: v3.4.2 to Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T13:21:31.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.2 instead of Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T17:39:44.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 in the site footer. No study data, eligibility criteria, outcomes, or navigation were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:44:12.000Z thumbnail image

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.